GSK3B and myocardial infarction: We found that the GSK3β inhibitor SB216763 significantly improved heart pump function, reduced myocardial infarct size and apoptosis in hypercholesterolemic rats, which suggests that the downstream signal mechanisms of GSK3β in hypercholesterolemic myocardium is preserved.